The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients

Blood Purification

Volumn 31, Issue 4, 2011, Pages 243-251

  Brener, Zachary Z ^a   Thijssen, Stephan ^a,b   Kotanko, Peter ^a,b   Kuhlmann, Martin K ^c   Bergman, Michael ^d   Winchester, James F ^a   Levin, Nathan W ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b RENAL RESEARCH INSTITUTE   (United States)

^c Vivantes Klinikum   (Germany)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Hemodialysis; Hospitalization; Mortality; Residual renal function

Indexed keywords

BICARBONATE; CALCIUM; CHOLESTEROL; PHOSPHATE; POTASSIUM; SERUM ALBUMIN;

AGE SPECIFIC CARE; ALBUMIN BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HEMATOCRIT; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78651386014     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000322252     Document Type: Article

References (32)

1. Termorshuizen F, Korevaar JC, Dekker FW, et al; NECOSAD Study Group: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003;41:1293-1302. (Pubitemid 36637986)
2. Morduchowicz G, Winkler J, Zabludowski JR, et al: Effects of residual renal function in hemodialysis patients. Int Urol Nephrol 1994;26:125-131. (Pubitemid 24151942)
3. Wang AY, Woo J, Wang M, et al: Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005;20:396-403. (Pubitemid 40276898)
4. Wang AY, Sea MM, Ip R, et al: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001;12:2450-2457. (Pubitemid 33021123)
5. Pecoits-Filho R, Heimburger O, Barany P, et al: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003;41:1212-1218. (Pubitemid 36637976)
6. Wang AY, Wang M, Woo J, et al: A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002;62:639-647. (Pubitemid 34779779)
7. Wang AY, Wang M, Woo J, et al: Inflammation, residual renal function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004;15:2186-2194. (Pubitemid 39031357)
8. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158-2162. (Pubitemid 32880353)
9. Shemin D, Bostom AG, Lambert C, et al: Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 2000;20:439-444.
10. Shemin D, Bostom AG, Laliberty P, Dworkin LD: Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38:85-90. (Pubitemid 32611763)
11. US Renal Data System: USRDS 2009 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
12. Chertow GM, Goldstein-Fuchs DJ, Lazarus JM, et al: Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int 2005;68:2794-2800. (Pubitemid 43251025)
13. Li S, Foley RN, Collins AJ: Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States. Kidney Int 2004;65:1864-1869. (Pubitemid 38591037)
14. Locatelli F, Pisoni RL, Combe C, et al: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004;19:121-132. (Pubitemid 38072623)
15. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999;10:610-619. (Pubitemid 29117643)
16. Rocco MV, Soucie MJ, Reboussin DM, McClellan WM: Risk factors for hospital utilization in chronic dialysis patients. J Am Soc Nephrol 1996;7:889-896.
17. Arora P, Kausz A, Obrador G, et al: Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 2000;11:740-746. (Pubitemid 30171883)
18. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006. (Pubitemid 23307908)
19. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT, NECOSAD Study Group: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004;15:1061-1070. (Pubitemid 38375326)
20. Tattersall J, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 1995;15:283-289.
21. Mix TC, St peter WL, Ebben J, et al: Hospitalization during advancing chronic kidney disease. Am J Kidney Dis 2003;42:972-981.
22. Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey AS: Level of renal function at the initiation of dialysis in the US endstage renal disease population. Kidney Int 1999;56:2227-2235. (Pubitemid 30004752)
23. Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJ: Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol 2000;11:2351-2357.
24. Combes A, Luvt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J: Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007;35:146-154. (Pubitemid 46035690)
25. Allon M, Radeva M, Bailey J, et al; HEMO Study Group: The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant 2005;20:1180-1186.
26. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 2000;58:346-352. (Pubitemid 30429881)
27. Wang AY, Lam CW, Wang M, et al: Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis 2005;45:715-729. (Pubitemid 40460760)
28. Pecoits-Filho R, Heimburger O, Barany P, et al: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003;41:1212-1218. (Pubitemid 36637976)
29. Shin SK, Noh H, Kang SW, et al: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999;19:138-142. (Pubitemid 30088064)
30. Cheung AK, Greene T, Leypoldt JK, et al: HEMO Study Group: Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 2008;3:69-77.
31. Ross EA, Alza RE, Jadeja NN: Hospital resource utilization that occurs with, rather than because of, kidney failure in patients with end-stage renal disease. Clin J Am Soc Nephrol 2006;1:1234-1240.
32. Brener ZZ, Kotanko P, Thijssen S, et al: Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci 2010;339:453-456.